Very Large Common Fragile Site Genes and Their Potential Role in Cancer Development

Overview

Journal Cell Mol Life Sci

Publisher Springer

Specialty Biology

Date 2014 Oct 11

PMID 25300511

Citations 29

Authors

Ge Gao

David I Smith

Affiliations

Soon will be listed here.

Abstract

Common fragile sites (CFSs) are large chromosomal regions that are hot-spots for alterations especially within cancer cells. The three most frequently expressed CFS regions (FRA3B, FRA16D and FRA6E) contain genes that span extremely large genomic regions (FHIT, WWOX and PARK2, respectively), and these genes were found to function as important tumor suppressors. Many other CFS regions contain extremely large genes that are also targets of alterations in multiple cancers, but none have yet been demonstrated to function as tumor suppressors. The loss of expression of just FHIT or WWOX has been found to be associated with a worse overall clinical outcome. Studies in different cancers have revealed that some cancers have decreased expression of multiple large CFS genes. This loss of expression could have a profound phenotypic effect on these cells. In this review, we will summarize the known large common fragile site genes and discuss their potential relationship to cancer development.

Citing Articles

Expression of Tumor Suppressor Is Regulated by the -SNAIL Axis in Human Lung Adenocarcinoma.

Suzuki T, Sakai S, Ota K, Yoshida M, Uchida C, Niida H Int J Mol Sci. 2023; 24(23).

PMID: 38069335 PMC: 10707390. DOI: 10.3390/ijms242317011.

Potential Role of the Fragile Histidine Triad in Cancer Evo-Dev.

Niu Z, Jiang D, Shen J, Liu W, Tan X, Cao G Cancers (Basel). 2023; 15(4).

PMID: 36831487 PMC: 9954361. DOI: 10.3390/cancers15041144.

Quaking but not parkin is the major tumor suppressor in 6q deleted region in glioblastoma.

Aksoy Yasar F, Shingu T, Zamler D, Zaman M, Chien D, Zhang Q Front Cell Dev Biol. 2022; 10:931387.

PMID: 36051438 PMC: 9424994. DOI: 10.3389/fcell.2022.931387.

Breaking the paradigm: early insights from mammalian DNA breakomes.

Saayman X, Esashi F FEBS J. 2021; 289(9):2409-2428.

PMID: 33792193 PMC: 9451923. DOI: 10.1111/febs.15849.

Unraveling the chaotic genomic landscape of primary and metastatic canine appendicular osteosarcoma with current sequencing technologies and bioinformatic approaches.

Chu S, Skidmore Z, Kunisaki J, Walker J, Griffith M, Griffith O PLoS One. 2021; 16(2):e0246443.

PMID: 33556121 PMC: 7870011. DOI: 10.1371/journal.pone.0246443.

References

Toledo G, Sola J, Dolores Lozano M, Soria E, Pardo J . Loss of FHIT protein expression is related to high proliferation, low apoptosis and worse prognosis in non-small-cell lung cancer. Mod Pathol. 2004; 17(4):440-8. DOI: 10.1038/modpathol.3800081. View

Trapasso F, Pichiorri F, Gaspari M, Palumbo T, Aqeilan R, Gaudio E . Fhit interaction with ferredoxin reductase triggers generation of reactive oxygen species and apoptosis of cancer cells. J Biol Chem. 2008; 283(20):13736-44. PMC: 2376222. DOI: 10.1074/jbc.M709062200. View

Dai J, Ram P, Yuan L, Spriggs L, Hill S . Transcriptional repression of RORalpha activity in human breast cancer cells by melatonin. Mol Cell Endocrinol. 2001; 176(1-2):111-20. DOI: 10.1016/s0303-7207(01)00449-x. View

Bloomston M, Kneile J, Butterfield M, Dillhoff M, Muscarella P, Ellison E . Coordinate loss of fragile gene expression in pancreatobiliary cancers: correlations among markers and clinical features. Ann Surg Oncol. 2009; 16(8):2331-8. PMC: 2719793. DOI: 10.1245/s10434-009-0507-4. View

Yang Q, Yoshimura G, Suzuma T, Tamaki T, Umemura T, Nakamura M . Clinicopathological significance of fragile histidine triad transcription protein expression in breast carcinoma. Clin Cancer Res. 2001; 7(12):3869-73. View

Helmrich A, Ballarino M, Tora L . Collisions between replication and transcription complexes cause common fragile site instability at the longest human genes. Mol Cell. 2011; 44(6):966-77. DOI: 10.1016/j.molcel.2011.10.013. View

Fong K, Biesterveld E, Virmani A, Wistuba I, Sekido Y, Bader S . FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations. Cancer Res. 1997; 57(11):2256-67. View

Turner B, Ottey M, Zimonjic D, Potoczek M, Hauck W, Pequignot E . The fragile histidine triad/common chromosome fragile site 3B locus and repair-deficient cancers. Cancer Res. 2002; 62(14):4054-60. View

Ishii H, Vecchione A, Furukawa Y, Sutheesophon K, Han S, Druck T . Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies. Mol Cancer Res. 2003; 1(13):940-7. View

10.

LaVoie M, Cortese G, Ostaszewski B, Schlossmacher M . The effects of oxidative stress on parkin and other E3 ligases. J Neurochem. 2007; 103(6):2354-68. DOI: 10.1111/j.1471-4159.2007.04911.x. View

11.

Mallaret M, Synofzik M, Lee J, Sagum C, Mahajnah M, Sharkia R . The tumour suppressor gene WWOX is mutated in autosomal recessive cerebellar ataxia with epilepsy and mental retardation. Brain. 2013; 137(Pt 2):411-9. PMC: 3914474. DOI: 10.1093/brain/awt338. View

12.

Ohta M, Inoue H, Cotticelli M, Kastury K, Baffa R, Palazzo J . The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell. 1996; 84(4):587-97. DOI: 10.1016/s0092-8674(00)81034-x. View

13.

Ni S, Hu J, Duan Y, Shi S, Li R, Wu H . Down expression of LRP1B promotes cell migration via RhoA/Cdc42 pathway and actin cytoskeleton remodeling in renal cell cancer. Cancer Sci. 2013; 104(7):817-25. PMC: 7657119. DOI: 10.1111/cas.12157. View

14.

Rozier L, El-Achkar E, Apiou F, Debatisse M . Characterization of a conserved aphidicolin-sensitive common fragile site at human 4q22 and mouse 6C1: possible association with an inherited disease and cancer. Oncogene. 2004; 23(41):6872-80. DOI: 10.1038/sj.onc.1207809. View

15.

Krummel K, Roberts L, Kawakami M, Glover T, Smith D . The characterization of the common fragile site FRA16D and its involvement in multiple myeloma translocations. Genomics. 2000; 69(1):37-46. DOI: 10.1006/geno.2000.6321. View

16.

Zhang P, Jia R, Ying L, Liu B, Qian G, Fan X . WWOX-mediated apoptosis in A549 cells mainly involves the mitochondrial pathway. Mol Med Rep. 2012; 6(1):121-4. DOI: 10.3892/mmr.2012.860. View

17.

Nagoshi H, Taki T, Hanamura I, Nitta M, Otsuki T, Nishida K . Frequent PVT1 rearrangement and novel chimeric genes PVT1-NBEA and PVT1-WWOX occur in multiple myeloma with 8q24 abnormality. Cancer Res. 2012; 72(19):4954-62. DOI: 10.1158/0008-5472.CAN-12-0213. View

18.

Ferber M, Thorland E, Brink A, Rapp A, Phillips L, McGovern R . Preferential integration of human papillomavirus type 18 near the c-myc locus in cervical carcinoma. Oncogene. 2003; 22(46):7233-42. DOI: 10.1038/sj.onc.1207006. View

19.

Holschneider C, Baldwin R, Tumber K, Aoyama C, Karlan B . The fragile histidine triad gene: a molecular link between cigarette smoking and cervical cancer. Clin Cancer Res. 2005; 11(16):5756-63. DOI: 10.1158/1078-0432.CCR-05-0234. View

20.

Thorland E, Myers S, Gostout B, Smith D . Common fragile sites are preferential targets for HPV16 integrations in cervical tumors. Oncogene. 2003; 22(8):1225-37. DOI: 10.1038/sj.onc.1206170. View